HIV-1 Tat Regulates Endothelial Cell Cycle Progression via Activation of the Ras/ERK MAPK Signaling Pathway
-
Published:2006-04
Issue:4
Volume:17
Page:1985-1994
-
ISSN:1059-1524
-
Container-title:Molecular Biology of the Cell
-
language:en
-
Short-container-title:MBoC
Author:
Toschi Elena1, Bacigalupo Ilaria1, Strippoli Raffaele2, Chiozzini Chiara1, Cereseto Anna3, Falchi Mario1, Nappi Filomena1, Sgadari Cecilia1, Barillari Giovanni4, Mainiero Fabrizio2, Ensoli Barbara1
Affiliation:
1. AIDS National Center, Istituto Superiore di Sanità, 00161 Rome, Italy 2. Department of Experimental Medicine and Pathology, Institute Pasteur-Fondazione Cenci Bolognetti, University La Sapienza, 00185 Rome, Italy 3. Laboratory of Molecular Biology, Scuola Normale Superiore, 56100 Pisa, Italy 4. Department of Experimental Medicine, University “Tor Vergata,” 00173 Rome, Italy
Abstract
Tat, the transactivator of HIV-1 gene expression, is released by acutely HIV-1-infected T-cells and promotes adhesion, migration, and growth of inflammatory cytokine-activated endothelial and Kaposi's sarcoma cells. It has been previously demonstrated that these effects of Tat are due to its ability to bind through its arginine-glycine-aspartic (RGD) region to the α5β1 and αvβ3 integrins. However, the signaling pathways linking Tat to the regulation of cellular functions are incompletely understood. Here, we report that Tat ligation on human endothelial cells results in the activation of the small GTPases Ras and Rac and the mitogen-activated protein kinase ERK, specifically through its RGD region. In addition, we demonstrated that Tat activation of Ras, but not of Rac, induces ERK phosphorylation. We also found that the receptor proximal events accompanying Tat-induced Ras activation are mediated by tyrosine phosphorylation of Shc and recruitment of Grb2. Moreover, Tat enabled endothelial cells to progress through the G1 phase in response to bFGF, and the process is linked to ERK activation. Taken together, these data provide novel evidence about the ability of Tat to activate the Ras-ERK cascade which may be relevant for endothelial cell proliferation and for Kaposi's sarcoma progression.
Publisher
American Society for Cell Biology (ASCB)
Subject
Cell Biology,Molecular Biology
Reference58 articles.
1. Albini, A., Barillari, G., Benelli, R., Gallo, R. C., and Ensoli, B. (1995). Angiogenic properties of human immunodeficiency virus type 1 Tat protein.Proc. Natl. Acad. Sci. USA92, 4838-4842. 2. Albini, A.et al.(1996). The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells.Nat. Med.2, 1371-1375. 3. Asthagiri, A. R., Nelson, C. M., Horwitz, A. F., and Lauffenburger, D. A. (1999). Quantitative relationship among integrin-ligand binding, adhesion, and signaling via focal adhesion kinase and extracellular signal-regulated kinase 2.J. Biol. Chem.274, 27119-27127. 4. Barillari, G., Buonaguro, L., Fiorelli, V., Hoffman, J., Michaels, F., Gallo, R. C., and Ensoli, B. (1992). Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis.J. Immunol.149, 3727-3734. 5. Barillari, G., Gendelman, R., Gallo, R. C., and Ensoli, B. (1993). The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence.Proc. Natl. Acad. Sci. USA90, 7941-7945.
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|